Gloucestershire Hospitals NHS Foundation Trust

The Gloucestershire Hospitals NHS Foundation Trust incorporates Gloucestershire Royal Hospital and Cheltenham General Hospital http://www.gloshospitals.nhs.uk/

View Trust Services

This trust offers the following services:

  • Diagnostic and pre-operative services:
    • On-site MRI liver facilities
    • On-site PET-CT facilities
    • Age Specific Genetic Testing for Lynch Syndrome
  • Oncology services:
    • On-site chemotherapy services
    • On-site External Beam Radiotherapy services
  • Advanced disease services:
    • Dedicated Specialist Advanced Nurse
    • Dedicated Specialist Advanced MDT
  • Support service facilities:
    • Dedicated nurses for ERAS services
    • Availability of 24 hour palliative care advice

Data Quality
All Patients: Trust Network National
Number of patients in Audit 423 1614 31676
Case ascertainment (%) 92 102 95
Data completeness of:
– Pre-treatment TNM (%) 66 82 80
– Performance status (%) 82 91 86
Patients having major resection: Trust Network National
Number of patients in Audit 286 971 19218
ASA grade 1 (%) 9 6 11
ASA grade 2 (%) 69 61 53
ASA grade 3 (%) 21 31 28
ASA grade 4+ (%) 1 2 3
ASA grade not recorded (%) N/A N/A 5
Data completeness of:
7 Audit items for risk-adjustment (%) 90 90 86

Key:

> 80%
50 - 80%
< 50%

Management of all patients
All Patients: Trust Network National
Number of patients in Audit 423 1614 31676
Seen by Clinical Nurse Specialist (%) 80 87 87
All patients deemed potentially curative Trust Network National
Number of potentially curative patients 99 369 7416
Undergoing major resection (%) 96 86 86

Management of patients having major resection
Patients having major resection: Trust Network National
Number of patients in Audit 286 971 19218
Distant metastases (%) 4 4 8
Urgent or emergency surgery (%) 9 13 15
At least 12 lymph nodes excised (%) 92 87 84
Laparoscopic surgery attempted (%) 70 77 69
Risk-adjusted length of stay > 5 days (%) 61 58 62
Patients having major resection for stage III colon cancer: Trust Network National
Number of patients in audit 182 656 11837
Adjuvant chemotherapy (%) 66 62 62

Rectal cancer patients
Patients having major resection: Trust Network National
Number of patients in Audit 70 252 4588
Neoadjuvant therapy (%) 31 26 33
Circumferential resection margin: Recorded (%) 90 84 90
Circumferential resection margin: Negative (%) 83 75 80
Rectal volume N/A N/A N/A
Patients in APER/Hartmanns estimate: Trust Network National
Number of patients in APER/Hartmanns estimate N/A N/A N/A
APER/Hartmanns (%) N/A N/A N/A

Compare trust outcomes

Copyright © 2024 National Bowel Cancer Audit | Lovingly Crafted by Mixd